UPDATE: Jefferies Upgrades Pfizer from Hold to Buy, Boosts Target to $38

Pfizer (NYSE: PFE ) has received an upgraded rating from Hold to Buy and a raised price target from $33 to $38 at Jefferies Tuesday morning. Pfizer's upgrades follows acknowledgments that Oncology and restructuring are key themes for the Pharma sector and Pfizer has both of those covered with palbociclib looking